Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

At 16.80% CAGR, Global Artificial Tendons and Ligaments Market Size to Hit USD 56.61 Million by 2028 | Artificial Tendons and Ligaments Industry Trends, Share, Price, Demand, Analysis & Forecast Report by Facts & Factors

Published

on

DUBLIN, Ireland, Jan. 12, 2023 (GLOBE NEWSWIRE) — Facts and Factors has published a new research report titled “Artificial Tendons and Ligaments Market Size, Share, Growth Analysis Report By Application (Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries, Spine Injuries, Hip Injuries, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Others), and By Region – Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028” in its research database.

The report analyses the Artificial Tendons and Ligaments market’s drivers and restraints, as well as the impact they have on-demand throughout the projection period. In addition, the report examines global opportunities in the global Artificial Tendons and Ligaments market.

Artificial Tendons and Ligaments Market Overview:

An area of connective tissue called a ligament binds two bones together. The ligament, a fibrous band of connective fibers, keeps the bones together at the joints and supports the internal organs. The two primary forms of the ligament are the white ligament, which is abundant in collagenous fibers, and the yellow ligament, which is abundant in elastic fibers.

An artificial tendon, a strengthening material, is used to replace a damaged tendon. Bio-compatible substances including PET (polyethylene terephthalate), polypropylene, and polyacrylonitrile are used to create artificial tendons (sodium styrene sulfonate). A team of researchers from the University of Utah’s biomedical department has developed a method to 3D print human tissue, including tendons and ligaments.

Get a Free Sample PDF of this Research Report for more Insights with Table of Content, Research Methodology, and Graphs – https://www.fnfresearch.com/sample/artificial-tendons-and-ligaments-market

(A free sample of this report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the Following:

  • Introduction, Overview, and in-depth industry analysis are all included in the 2023 updated report.
  • About 211+ Pages Research Report
  • Provide detailed chapter-by-chapter guidance on Request
  • Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2023
  • Includes Tables and figures have been updated
  • The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, Revenue Analysis, SWOT Analysis, Historical and Forecast Growth, Porter’s 5 Forces Analysis
  • Facts and Factors research methodology

Key Insights from Primary Research

  • As per the analysis, the Artificial Tendons and Ligaments market is likely to grow above a CAGR of around 16.80% between 2022 and 2028.
  • The Artificial Tendons and Ligaments market size was worth around US$ 19.09 Million in 2021 and is estimated to hit approximately US$ 56.61 Million by 2028. Due to a variety of driving factors, the market is predicted to rise at a significant rate.
  • Based on application segmentation, knee injuries were predicted to show maximum market share in the year 2021
  • Based on end user segmentation, hospital and clinics had the leading revenue-generating applications in 2021.
  • On the basis of region, North America was the leading revenue generator in 2021.

Industry Growth Dynamics

A few of the factors driving the growth of the global artificial tendons and ligaments market include increasing sports injury rates, expanding government programs to raise public awareness of artificial tendons & ligaments, and increasing R&D spending on artificial tendons & ligaments. The global market for artificial tendons and ligaments will expand as a result of the aging population’s challenges with tendon and ligament degradation and the rising demand for minimally invasive procedures. The key barriers to the expansion of the global artificial tendons and ligaments market are healthcare professionals’ resistance to using artificial tendons and ligaments, the high cost of therapy, and poor reimbursement policies.

The primary element influencing the market is the rise in sports injuries. The majority of injuries sustained when participating in sports are the result of accidents, poor technique, insufficient warm-up & stretching, and a lack of conditioning. Among the most frequent sports injuries among athletes are tennis elbow, ankle sprains, groyne pulls, hamstring strains, and ACL tears.

Furthermore, a sizeable percentage of people are unaware of the safety precautions that are applicable to sports, which can result in a range of minor to severe injuries. Approximately 165,000 sports-related injuries were treated in A&E departments in England in 2016, according to Accident & Emergency (A&E) data made public by the U.K. Parliament.

Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/artificial-tendons-and-ligaments-market

Competitive Players

The report contains qualitative and quantitative research on the global artificial tendons and ligaments market, as well as detailed insights and development strategies employed by the leading competitors. The report also provides an in-depth analysis of the market’s main competitors, as well as information on their competitiveness.

The research also identifies and analyses important business strategies used by these main market players, such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts. The study examines, among other things, each company’s global presence, competitors, service offers, and standards.

Some of the main players in the global artificial tendons and ligaments market include;

  • Mathys AG Bettlach
  • FX Solutions
  • LARS
  • Cousin Biotech
  • Orthomed S.A.S
  • Shanghai PINE&POWER Biotech

Browse the full “Artificial Tendons and Ligaments Market Size, Share, Growth Analysis Report By Application (Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries, Spine Injuries, Hip Injuries, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Others), and By Region – Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028” Report at https://www.fnfresearch.com/artificial-tendons-and-ligaments-market

Artificial Tendons and Ligaments Market: Segmentation Analysis

The global artificial tendons and ligaments market is segmented based on application, end user, and region.

Based on application, the market is segmented into knee injuries, shoulder injuries, foot & ankle injuries, spine injuries, hip injuries, and others. Due to a variety of factors, including an increase in sports participation, an increase in the frequency of knee injuries, discomfort at the harvest site as a result of conventional surgical treatment methods using autografts and allografts, and the advantages of artificial tendons and ligaments over autografts and allografts, the knee injuries segment dominated the global artificial tendons and ligaments market.

The other uses category includes conditions such as hip dislocation, elbow injuries, and spinal injuries. The segment is anticipated to expand rapidly as a result of the rise in entire femoral tumor removals and prosthetic replacement surgeries, both of which have high success rates. Among the significant products in this area are Cousin Biotech’s NAJA and IntraSpine, LARS, and InternalBrace.

By end user, the market is divided into hospitals, specialty clinics, ambulatory surgery centers, and others. Due to a high risk of postoperative problems and high patient turnover, the hospitals segment led the global artificial tendons and ligaments market. Supportive infrastructure, which assists in efficient operations, will also encourage the adoption of these grafts in hospitals and clinics’ end-user facilities.

Regional Dominance:

During the anticipated period, Europe will drive the global artificial tendons and ligaments market growth. The growth of the medical device industry, the low out-of-pocket costs for medical devices, increased government initiatives to promote sports, an increase in conferences, symposiums, and workshops in the UK showcasing the newest sports technologies, an increase in sports-related injuries and knee replacements, and agreements between universities, organizations, and institutions have all contributed to the Europe region currently holding a dominant share of the global market.

Have Any Query? Ask Our Experts: https://www.fnfresearch.com/inquiry/artificial-tendons-and-ligaments-market

Recent Industry Developments:

  • In June 2018, a team of Swiss researchers developed a microplate system for printing engineered muscle and tendon tissue. This system may help as a therapeutic application to treat a variety of muscle disorders.
  • In January 2018, a team of scientists from the University of Colorado Boulder engineered a humanlike artificial muscle that is cheap, flexible and strong.

Key questions answered in this report:

  • What is the market size and growth rate forecast for Artificial Tendons and Ligaments industry?
  • What are the main driving factors propelling the Artificial Tendons and Ligaments Market forward?
  • What are the leading companies in the Artificial Tendons and Ligaments Industry?
  • What segments does the Artificial Tendons and Ligaments Market cover?
  • How can I receive a free copy of the Artificial Tendons and Ligaments Market sample report and company profiles?

Report Scope:

Report Attribute Details
Market Size in 2021 USD 19.09 Million
Projected Market Size in 2028 USD 56.61 Million
CAGR Growth Rate 16.80% CAGR
Base Year 2021
Forecast Years 2022-2028
Key Market Players Mathys AG Bettlach, FX Solutions, LARS, Cousin Biotech, Orthomed S.A.S, Shanghai PINE&POWER Biotech, and others.
Key Segment By Application, End User, and Region
Major Regions Covered North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa
Purchase Options Request customized purchase options to meet your research needs.

Request for Customization on this Report as per your requirements – https://www.fnfresearch.com/customization/artificial-tendons-and-ligaments-market

(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)

The global Artificial Tendons and Ligaments market is segmented as follows:

By Application

  • Knee Injuries
  • Shoulder Injuries
  • Foot & Ankle Injuries
  • Spine Injuries
  • Hip Injuries
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
    • Rest of Southeast Asia
  • The Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

To know an additional revised 2023 list of market players, request a sample report: https://www.fnfresearch.com/sample/artificial-tendons-and-ligaments-market

Key Offerings:

  • Market Size, Trends, & Forecast by Revenue | 2022−2028
  • Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
  • Market Segmentation – A detailed analysis by Application, End User, and Region
  • Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Browse Other Related Research Reports from Facts & Factors

About Facts & Factors:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:

Facts & Factors

USA: +1 347 690-0211 | UK: +44 2032 894158 | Japan: +81 50 5806 9039 | India: +91 73877 19999

Email: [email protected] | Web: https://www.fnfresearch.com

Follow Us on – LinkedIn | Twitter | Facebook

 Also Read Our Blogs:

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Clarivate Declares Dividend on Mandatory Convertible Preferred Shares

Published

on

clarivate-declares-dividend-on-mandatory-convertible-preferred-shares

LONDON, May 1, 2024 /PRNewswire/ — Clarivate Plc (NYSE: CLVT; CLVT PR A) (“Clarivate”), a leading global provider of transformative intelligence, today announced that its board of directors declared a quarterly dividend of $1.3125 per share on its 5.25% Series A Mandatory Convertible Preferred Shares (the “Preferred Shares”), payable in cash on June 3, 2024 to shareholders of record at the close of business on May 15, 2024.

On the mandatory conversion date, which is scheduled to occur on June 3, 2024, each Preferred Share will automatically and mandatorily convert into a number of ordinary shares of Clarivate (and cash in lieu of any fractional ordinary shares) based on the average volume weighted average price (“VWAP”) of Clarivate’s ordinary shares over a 30-trading day period that begins on, and includes, April 18, 2024 and is scheduled to end on, and include, May 30, 2024 (the “valuation period”). If such VWAP is (i) greater than $31.20, then the mandatory conversion rate will be 3.2052 ordinary shares of Clarivate per Preferred Share, (ii) less than or equal to $31.20 but equal to or greater than $26.00, then the mandatory conversion rate will be a number of ordinary shares of Clarivate per Preferred Share equal to $100.00 divided by such VWAP and (iii) less than $26.00, then the mandatory conversion rate will be 3.8462 ordinary shares of Clarivate per Preferred Share. The mandatory conversion rate will be announced following the end of the valuation period. The above description of the terms of the Preferred Shares is not complete and is subject to, and qualified in its entirety by reference to, the “Statement of Rights” for the Preferred Shares, which is filed as Exhibit 3.2 to Clarivate’s annual report on Form 10-K for the fiscal year ended December 31, 2023.
Cautionary Note Regarding Forward-Looking Statements
This communication contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements, which express management’s current views concerning future business, events, trends, contingencies, financial performance, or financial condition, appear at various places in this communication and may use words like “aim,” “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “future,” “goal,” “intend,” “likely,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “see,” “seek,” “should,” “strategy,” “strive,” “target,” “will,” and “would” and similar expressions, and variations or negatives of these words. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management’s current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include those factors discussed under the caption “Risk Factors” in our annual report on Form 10-K, along with our other filings with the U.S. Securities and Exchange Commission (“SEC”). However, those factors should not be considered to be a complete statement of all potential risks and uncertainties. Additional risks and uncertainties not known to us or that we currently deem immaterial may also adversely affect our business operations. Forward-looking statements are based only on information currently available to our management and speak only as of the date of this communication. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, except as otherwise required by securities and other applicable laws. Please consult our public filings with the SEC or on our website at www.clarivate.com.
About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com.
Logo – https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/clarivate-declares-dividend-on-mandatory-convertible-preferred-shares-302133633.html

Continue Reading

Artificial Intelligence

CGTN: 3rd CMG Forum in Beijing discusses AI development

Published

on

cgtn:-3rd-cmg-forum-in-beijing-discusses-ai-development

BEIJING, May 1, 2024 /PRNewswire/ — Focusing on the development of AI, the third CMG Forum was held on Monday in Beijing.

Li Shulei, a member of the Political Bureau of the Communist Party of China (CPC) Central Committee and the head of the Publicity Department of the CPC Central Committee, attended the opening of the event and delivered a speech.
Guests at the forum stressed the role of media in promoting the innovative application of AI as well as its governance.
Efforts should also be made to boost the development of AI in creating positive, healthy, diverse and high-quality content, so that AI can become a force for good and benefit mankind, they agreed.
They also called on media to accelerate intelligent transformation and help bridge international exchanges and cooperation on the governance of AI to facilitate its healthy, orderly and safe development.
Hosted by China Media Group (CMG), the forum attracted more than 200 participants from international organizations, media, think tanks and multinational companies.
“Innovation and breakthroughs in science and technology not only guide the development and progress of human civilization, but also bring uncertainty to the changing world,” said Shen Haixiong, vice minister of the Publicity Department of the CPC Central Committee and president of CMG. He called for efforts to jointly create valuable and responsible artificial intelligence.
AI technology is affecting every aspect of our lives. Thomas Bach, president of the International Olympic Committee (IOC), stated in a video speech that CMG has always been a partner of the IOC, bringing the charm of the Olympic Games to hundreds of millions of Chinese viewers. He said the IOC invites CMG to work together for the creation of a future with the application of AI in Olympic sports.
“From ancient inventions such as silk, printing and the compass to modern technological advances such as robotics, telecommunications and green technology, China has always been committed to innovation and creation,” said Daren Tang, director general of the World Intellectual Property Organization (WIPO). He said WIPO pays close attention to ensuring a balance between the opportunities and risks of artificial intelligence and is committed to strengthening cooperation to ensure that artificial intelligence is properly used.
https://news.cgtn.com/news/2024-04-30/3rd-CMG-Forum-in-Beijing-discusses-AI-development-1tdDcXvCexG/p.html

View original content:https://www.prnewswire.co.uk/news-releases/cgtn-3rd-cmg-forum-in-beijing-discusses-ai-development-302133410.html

Continue Reading

Artificial Intelligence

Trianz Appoints Sridhar Kannan as Practice Leader – Digital, Elevating its Leadership in the Global Digital Transformation Space

Published

on

trianz-appoints-sridhar-kannan-as-practice-leader-–-digital,-elevating-its-leadership-in-the-global-digital-transformation-space

SANTA CLARA, Calif., May 1, 2024 /PRNewswire/ — Digital transformation technology & services company Trianz is pleased to announce the appointment of Sridhar Kannan as Practice Leader – Digital. With over 25 years of extensive experience in technology and business leadership, Sridhar joins Trianz to lead the expansion of Trianz’s Digital Practice, forging strategic alliances and expanding the business footprint.

Sridhar’s appointment comes at a transformative phase for Trianz as it solidifies its commitment to redefining the digital landscape with an “IP Led” model. This strategic shift is powered by Trianz’s cutting-edge hyper-automated platforms, Concierto.Cloud, Extrica.AI, and Pulse, driving industry-leading transformations in cloud, data and analytics, AI, and the digital workplace. Sridhar’s visionary leadership in technology-led business transformations across diverse sectors will be instrumental in leveraging IP-led models and innovative methodologies to position Trianz at the forefront of digital transformation.
“We are thrilled to welcome Sridhar Kannan to the Trianz family,” said Seshi Vanguru, Chief Revenue Officer at Trianz. “His appointment marks a significant stride in Trianz’s journey toward innovation and excellence. Sridhar’s wealth of experience and exceptional leadership skills will elevate our Digital Practice to new heights, reaffirming our commitment to delivering exceptional value to our clients.”
Sridhar is recognized as a client-focused technology and business transformation executive with a remarkable track record of helping Banking and Financial Services organizations in business transformation and product innovation using applications, cloud, data, and digital solutions. His extensive prior experience at industry giants such as Wipro, Cognizant, and Infosys include successfully leading Fortune 10 global client relationships and implementing transformative solutions across Banking, Financial Services, and Healthcare industries. Sridhar is highly regarded for his ability to lead global cross-functional teams, foster collaboration, and achieve aggressive business goals while consistently delivering high levels of client satisfaction.
“I am deeply honored to join Trianz and contribute to its mission of shaping the future through digital transformation,” said Sridhar. “Together, we will push the boundaries of what’s possible and drive meaningful impact for our clients in this rapidly evolving digital landscape.”
Based out of Minnesota, US, Sridhar has steered numerous clients towards success through the strategic application of Digital, Cloud, Product Engineering, Data, AI, and Application services, making him a seasoned strategist in today’s dynamic digital landscape. His appointment marks a significant milestone in Trianz’s journey to nurturing talent and delivering world-class solutions.
About Trianz
Trianz is a leading-edge technology platforms and services company that accelerates digital transformations at Fortune 100 and emerging companies worldwide in data & analytics, digital experiences, cloud infrastructure, and security. Our “IP Led Transformations” approach, informed by insights from a recent global study spanning 20+ industries and 5000+ companies, addresses challenges posed by the rapid pace of AI-driven transformation, digital talent scarcity, and economic uncertainty. Our IP and platforms, including Concierto, Extrica, and Pulse, revolutionize cloud adoption, data analytics, and AI insights, empowering organizations to navigate the complexities of digital transformation seamlessly.
Founded in California and with an organization of over 2,000 associates across the United States and India, Trianz is a Premier Partner of AWS, consistently rated #1 by clients for value delivery over the past five years. Trianz has been ranked as one of the best Consulting Firms by Forbes and has been certified as a Great Place to Work for three years in a row. To learn more about Trianz, email [email protected] or visit www.trianz.com.
Watch Trianz CEO Sri Manchala’s insightful interview with Bloomberg on Partner | Crossing The Digital Faultline & Leading Towards Transformative Success – YouTube and delve deeper into his book Crossing the Digital Faultline at Crossing the Digital Faultline | Trianz.
Trianz Media Team : [email protected]+1-408-387-5800
Logo: https://mma.prnewswire.com/media/626944/1199800/Trianz_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/trianz-appoints-sridhar-kannan-as-practice-leader–digital-elevating-its-leadership-in-the-global-digital-transformation-space-302132835.html

Continue Reading

Trending